C07D 239/08
With hetero atoms directly attached in position 2
Official title: with hetero atoms directly attached in position 2
C07D239/08 (With hetero atoms directly attached in position 2) appears on 425 US grants and 274 published applications in this corpus.
Search patents in C07D- Granted patents
- 425
- Published applications
- 274
- Assignees
- 249
- Inventors
- 1,287
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 5 | 0 |
| 1978 | 3 | 0 |
| 1979 | 7 | 0 |
| 1980 | 5 | 0 |
| 1981 | 10 | 0 |
| 1982 | 7 | 0 |
| 1983 | 7 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 7 | 0 |
| 1987 | 2 | 0 |
| 1988 | 7 | 0 |
| 1989 | 11 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 3 | 0 |
| 1993 | 7 | 0 |
| 1994 | 7 | 0 |
| 1995 | 13 | 0 |
| 1996 | 6 | 0 |
| 1997 | 18 | 0 |
| 1998 | 21 | 0 |
| 1999 | 14 | 0 |
| 2000 | 13 | 0 |
| 2001 | 13 | 4 |
| 2002 | 24 | 20 |
| 2003 | 15 | 19 |
| 2004 | 14 | 21 |
| 2005 | 11 | 18 |
| 2006 | 8 | 12 |
| 2007 | 6 | 7 |
| 2008 | 9 | 10 |
| 2009 | 4 | 8 |
| 2010 | 8 | 17 |
| 2011 | 4 | 8 |
| 2012 | 12 | 11 |
| 2013 | 14 | 13 |
| 2014 | 14 | 13 |
| 2015 | 12 | 11 |
| 2016 | 10 | 8 |
| 2017 | 7 | 5 |
| 2018 | 8 | 11 |
| 2019 | 8 | 7 |
| 2020 | 4 | 7 |
| 2021 | 2 | 11 |
| 2022 | 7 | 5 |
| 2023 | 6 | 11 |
| 2024 | 5 | 13 |
| 2025 | 5 | 1 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for producing uracil compound1 Sep 2026US 12,723,032 B2Nippon Soda Co., Ltd.
- Compound and composition as PDGF receptor kinase inhibitor30 Dec 2025US 12,509,424 B2Nippon Shinyaku Co., Ltd.
- Cross-linked nucleoside and nucleotide using same18 Nov 2025US 12,473,299 B2Japan AS Represented By Director General of National Institute of Health Sciences
- Aryl-n-aryl derivatives for treating a RNA virus infection23 Sep 2025US 12,421,206 B2Abivax
- Solid state forms of mavacamten and process for preparation thereof25 Mar 2025US 12,258,320 B2Assia Chemical Industries Ltd.
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
- Ionizable lipidoid compositions and therapeutic uses thereof9 Apr 2026US 2026/0098014 A1Flagship Pioneering Innovations Vii, LLC
- Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid26 Mar 2026US 2026/0085051 A1Adama Agan Ltd.
- Low temperature synthesis of carbonyl-containing molecules by depolymerization of bisphenol a-based polycarbonates6 Mar 2025US 2025/0074851 A1Basque Center for Macromolecular Design and Engineering, Polymat Fundazioa
- Cyclic urea kras inhibitors31 Oct 2024US 2024/0358702 A1Incyte Corporation
Most cited
By later US patents
- Heterocyclic compounds114US 4,742,060 ANihon Tokushu Noyaku Seizo K. K. · 1988
- Retroviral protease inhibiting compounds86US 5,914,332 AAbbott Laboratories · 1999
- Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof83US 6,441,172 B1Torrey Pines Institute for Molecular Studies · 2002
- Meta-substituted phenylene derivatives72US 5,773,646 AG. D. Searle & Co. · 1998
- Catechol diethers as selective PDE.sup.IV inhibitors71US 5,814,651 APfizer Inc. · 1998